These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 9192831

  • 1. Quiescence in R3327-G rat prostate tumors after androgen ablation.
    Pollack A, Joon DL, Wu CS, Sikes C, Hasegawa M, Terry NH, White RA, Zagars GK, Meistrich ML.
    Cancer Res; 1997 Jun 15; 57(12):2493-500. PubMed ID: 9192831
    [Abstract] [Full Text] [Related]

  • 2. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
    Brändström A, Westin P, Bergh A, Cajander S, Damber JE.
    Cancer Res; 1994 Jul 01; 54(13):3594-601. PubMed ID: 8012987
    [Abstract] [Full Text] [Related]

  • 3. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ, Dionne CA, Jani J, Angeles T, Murakata C, Lamb J, Isaacs JT.
    Cancer Res; 1999 May 15; 59(10):2395-401. PubMed ID: 10344749
    [Abstract] [Full Text] [Related]

  • 4. Measurement of the proliferative activity of three different sublines of the Dunning rat prostate tumor R3327.
    Lohr F, Wenz F, Flentje M, Peschke P, Hahn EW.
    Strahlenther Onkol; 1993 Jul 15; 169(7):438-45. PubMed ID: 8342118
    [Abstract] [Full Text] [Related]

  • 5. Beneficial effects of androgen-primed chemotherapy in the Dunning R3327 G model of prostatic cancer.
    English HF, Heitjan DF, Lancaster S, Santen RJ.
    Cancer Res; 1991 Apr 01; 51(7):1760-5. PubMed ID: 2004359
    [Abstract] [Full Text] [Related]

  • 6. Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer.
    Hall SJ, Mutchnik SE, Yang G, Timme TL, Nasu Y, Bangma CH, Woo SL, Shaker M, Thompson TC.
    Cancer Gene Ther; 1999 Apr 01; 6(1):54-63. PubMed ID: 10078964
    [Abstract] [Full Text] [Related]

  • 7. The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions.
    Pollack A, Ashoori F, Sikes C, Joon DL, von Eschenbach AC, Zagars GK, Meistrich ML.
    Int J Radiat Oncol Biol Phys; 2000 Jan 01; 46(1):153-8. PubMed ID: 10656387
    [Abstract] [Full Text] [Related]

  • 8. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
    Rocchi P, Beraldi E, Ettinger S, Fazli L, Vessella RL, Nelson C, Gleave M.
    Cancer Res; 2005 Dec 01; 65(23):11083-93. PubMed ID: 16322258
    [Abstract] [Full Text] [Related]

  • 9. Unusual androgen sensitivity of the androgen-independent Dunning R-3327-G rat prostatic adenocarcinoma: androgen effect on tumor cell loss.
    Humphries JE, Isaacs JT.
    Cancer Res; 1982 Aug 01; 42(8):3148-56. PubMed ID: 7093958
    [Abstract] [Full Text] [Related]

  • 10. Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation.
    Joon DL, Hasegawa M, Sikes C, Khoo VS, Terry NH, Zagars GK, Meistrich ML, Pollack A.
    Int J Radiat Oncol Biol Phys; 1997 Jul 15; 38(5):1071-7. PubMed ID: 9276374
    [Abstract] [Full Text] [Related]

  • 11. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB, Nelson JB, Denmeade SR, Isaacs JT.
    Clin Cancer Res; 1997 Dec 15; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [Abstract] [Full Text] [Related]

  • 12. Prostatic tumor regrowth after initially successful castration therapy may be related to a decreased apoptotic cell death rate.
    Landström M, Damber JE, Bergh A.
    Cancer Res; 1994 Aug 15; 54(16):4281-4. PubMed ID: 7913874
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
    Fraizer G, Leahy R, Priyadarshini S, Graham K, Delacerda J, Diaz M.
    Int J Oncol; 2004 Mar 15; 24(3):461-71. PubMed ID: 14767530
    [Abstract] [Full Text] [Related]

  • 15. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
    Johansson A, Jones J, Pietras K, Kilter S, Skytt A, Rudolfsson SH, Bergh A.
    Prostate; 2007 Nov 01; 67(15):1664-76. PubMed ID: 17854058
    [Abstract] [Full Text] [Related]

  • 16. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
    Rabbani SA, Gladu J.
    Cancer Res; 2002 Apr 15; 62(8):2390-7. PubMed ID: 11956102
    [Abstract] [Full Text] [Related]

  • 17. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer.
    Miyake H, Nelson C, Rennie PS, Gleave ME.
    Cancer Res; 2000 Jan 01; 60(1):170-6. PubMed ID: 10646870
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug 01; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

  • 20. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
    Siu SW, Lau KW, Tam PC, Shiu SY.
    Prostate; 2002 Jul 01; 52(2):106-22. PubMed ID: 12111702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.